GLP-1 drug spending drives 15% of 2027 cost surge
Resolves: Aon or equivalent report attributes ≥15% of 2027 employer health cost growth to GLP-1 drug spending.
user-generated· healthcare
GLP-1 drug spending drives 15% of 2027 cost surge
Market overview
GLP-1 drug utilization will account for at least 15% of the 9.5% 2027 health cost increase.
healthcare prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-12-31
About this prediction
Resolution criteria
Aon or equivalent report attributes ≥15% of 2027 employer health cost growth to GLP-1 drug spending.
Source: user-generated
More healthcare markets
- ACA enrollment drops exceed 3 million by Q4 2026 — 80% Yes
- Pediatrician visits for MMR split increase by 20% — 60% Yes
- Obamacare enrollment will fall below 10 million by 2027 — 75% Yes
- Obamacare enrollment in Ohio will drop by over 40% by 2028 — 70% Yes
- State-level Medicaid work requirements reduce enrollment by 15% — 70% Yes
- National Obamacare enrollment will drop below 10 million by 2027 — 80% Yes
- Medicaid work requirements reduce enrollment by 10% or more in 2026 — 68% Yes
- Ohio's Obamacare enrollment will further decline by 20% by 2027 — 75% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…